![Ian Walters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Walters
Vorstandsvorsitzender bei
SalvaRx Ltd.
Profil
Ian B. Walters, Gründer der SalvaRx Group Plc, ist gegenwärtig Chief Executive Officer & Director bei Portage Biotech, Inc. sowie Chief Executive Officer & Director bei iOX Therapeutics Ltd. (eine Tochtergesellschaft von Portage Biotech, Inc.) und Chief Medical Officer & Vice President bei Intensity Therapeutics, Inc. Ian B. Walters ist auch im Vorstand von Enzo Biochem, Inc. und RIFT biotherapeutics, Inc. In seiner früheren Karriere war er Chief Executive Officer der SalvaRx Group Plc, SVP-Translational Medicine & Corporate Development bei Sorrento Therapeutics, Inc. und Mitglied der Bristol-Myers Squibb Canada Co. Er erhielt einen Doktortitel vom Albert Einstein College of Medicine, Inc. und einen MBA von der Wharton School der University of Pennsylvania.
Aktive Positionen von Ian Walters
| Unternehmen | Position | Beginn |
|---|---|---|
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Direktor/Vorstandsmitglied | 01.07.2015 |
Stimunity SAS
 Stimunity SAS BiotechnologyHealth Technology Provides biotechnology services | Vorsitzender | - |
SalvaRx Ltd.
 SalvaRx Ltd. BiotechnologyHealth Technology Develops therapies in immuno-oncology market | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Ian Walters
| Unternehmen | Position | Ende |
|---|---|---|
| ALPHA COMPUTE CORP | Vorstandsvorsitzender | 14.12.2024 |
| INTENSITY THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2023 |
| SALVARX GROUP PLC | Gründer | 08.01.2019 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Designs, develops and wholesales pharmaceutical services | Geschäftsführer | 01.03.2014 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ian Walters
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Enzo Biochem, Inc.
 Enzo Biochem, Inc. BiotechnologyHealth Technology Provides enabling life science technologies for research, drug discovery, drug development and diagnostic solutions | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
3Legs Resources Plc
 3Legs Resources Plc Financial ConglomeratesFinance Invests in acquired companies within the technology sector | Finance |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Designs, develops and wholesales pharmaceutical services | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SalvaRx Ltd.
SalvaRx Ltd. BiotechnologyHealth Technology Develops therapies in immuno-oncology market | Health Technology |
iOx Therapeutics Ltd.
iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company that focuses on immune-oncology & invests in novel cancer immune-therapies | Commercial Services |
RIFT biotherapeutics, Inc.
 RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibodies for use in oncology | Commercial Services |
Stimunity SAS
Stimunity SAS BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Wählen Sie MarketScreener 
